The epidemiological transition has been characterized by demographic, societal and health changes in societies. Presuming that acute diseases, mostly of communicable etiology, are more important in terms of early-life mortality, whereas chronic diseases are responsible for a greater burden of disease throughout the life course, we attempt to develop an index to measure the stage of the epidemiological transition. Using Global Burden of Diseases, Risk Factors and Injuries (GBD) data available at https://vizhub.healthdata.org/gbd-compare/ on 04/04/2024 to calculate the Epidemiologic Transition Estimate (ETE) index as a ratio of YLD/YLL for the time period of 1990-2019. The values of the index ranged from 0.131 to 1.067 and 0.180 to 2.108 for males and females, respectively, across the 195 included countries. The transition process seems to be faster to females compared to males. The index shows consistently increasing values for five SDI-based country groups, with clear differences among the groups. Although more research and validation studies are needed despite all the uncertainties, the index seems to be robust to assess the progress in epidemiological transition. These findings can help to predict future social care and health system needs to address causes leading to YLD or YLL.

Olomouc University Social Health Institute Palacky University Olomouc Katerinska 653 17 77900 Olomouc Czech Republic

Unit for Health Promotion Research University of Southern Denmark Degnevej 14 6700 Esbjerg Denmark

Zobrazit více v PubMed

Omran, A. R. The epidemiologic transition: A theory of the epidemiology of population change. Milbank Q.83, 731–757. 10.1111/j.1468-0009.2005.00398.x (2005). PubMed PMC

Oni, T. & Unwin, N. Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: Iimplications of multimorbidity for health systems in an era of health transition. Int. Health. 7, 390–399. 10.1093/inthealth/ihv040 (2015). PubMed PMC

Frenk, J. & Moon, S. Governance challenges in global health. N Engl. J. Med.368, 936–942. 10.1056/NEJMra1109339 (2013). PubMed

Agyei-Mensah, S. & de-Graft Aikins, A. Epidemiological transition and the double burden of disease in Accra, Ghana. J. Urban Health. 87, 879–897. 10.1007/s11524-010-9492-y (2010). PubMed PMC

Boutayeb, A. The double burden of communicable and non-communicable diseases in developing countries. Trans. R Soc. Trop. Med. Hyg.100, 191–199. 10.1016/j.trstmh.2005.07.021 (2006). PubMed

Bygbjerg, I. C. Double burden of noncommunicable and infectious diseases in developing countries. Science337, 1499–1501. 10.1126/science.1223466 (2012). PubMed

Kuate Defo, B. Beyond the ‘transition’ frameworks: The cross-continuum of health, disease and mortality framework. Glob Health Action. 10.3402/gha.v7.24804 (2014). PubMed PMC

Temu, F., Leonhardt, M., Carter, J. & Thiam, S. Integration of non-communicable diseases in health care: Tackling the double burden of disease in African settings. Pan Afr. Med. J.10.11604/pamj.2014.18.202.4086 (2014). PubMed PMC

de Matos, R. C., do Nascimento, G., Fernandes, A. C. & Matos, C. Implementation and impact of integrated health and social care services: An umbrella review. J. Public. Health Pol.45, 14–29. 10.1057/s41271-023-00465-y (2024). PubMed

Murray, C. J. L. (ed) The Global Burden of Disease: Summary; a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected To 2020 (Harvard School of Public health on behalf of the World Health organization and the World Bank, 1996).

Martinez, R., Soliz, P., Caixeta, R. & Ordunez, P. Reflection on modern methods: Years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality. Int. J. Epidemiol.48, 1367–1376. 10.1093/ije/dyy254 (2019). PubMed PMC

Institute of Health Metrix and Evaluation (IHME). Global Burden of Disease (GBD) n.d. accessed May 10, (2024). https://www.healthdata.org/research-analysis/about-gbd

Institute of Health Metrix and Evaluation (IHME). Countries | GHDx n.d. Accessed 10 May (2024). https://ghdx.healthdata.org/countries

Lim, S. S. et al. Measuring the health-related sustainable development goals in 188 countries: A baseline analysis from the global burden of disease study 2015. Lancet388, 1813–1850. 10.1016/S0140-6736(16)31467-2 (2016). PubMed PMC

Pallardy, R. Accessed 13 February 2010 Haiti earthquake | Magnitude, Damage, Map, & Facts | Britannica 2025. (2025). https://www.britannica.com/event/2010-Haiti-earthquake

Clark, S. & Hamplová, D. Single motherhood and child mortality in Sub-Saharan Africa: A life course perspective. Demography50, 1521–1549. 10.1007/s13524-013-0220-6 (2013). PubMed

Li, X. et al. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: A modelling study. Lancet397, 398–408. 10.1016/S0140-6736(20)32657-X (2021). PubMed PMC

Nayİr, T., Nazlican, E., Şahİn, M. & Kara, F. Effects of immunization program on morbidity and mortality rates ofvaccine-preventable diseases in Turkey. Turk. J. Med. Sci.50, 1909–1915. 10.3906/sag-2008-177 (2020). PubMed PMC

Petersen, I., Bhana, A., Lund, C. & Herrman, H. Primary Prevention of Mental Disorders. Early Intervention in Psychiatryp. 117–133 (Wiley, 2014). 10.1002/9781118557174.ch11

Wamba, A. A., Takah, N. F. & Johnman, C. The impact of interventions for the primary prevention of hypertension in Sub-Saharan Africa: A systematic review and meta-analysis. PLOS ONE. 14, e0219623. 10.1371/journal.pone.0219623 (2019). PubMed PMC

Simeonsson, R. J. Primary, secondary, and tertiary prevention in early intervention. J. Early Interv. 15, 124–134. 10.1177/105381519101500202 (1991).

Straka, J., Šídlo, L. & Kulhánová, I. Trends in healthy life years between 2005 and 2019 in 31 European countries: The compression or expansion of morbidity?? Int. J. Public. Health. 69, 1607574. 10.3389/ijph.2024.1607574 (2024). PubMed PMC

Stallard, E. Compression of morbidity and mortality: New perspectives. N Am. Actuar. J.20, 341–354. 10.1080/10920277.2016.1227269 (2016). PubMed PMC

Rieker, P. P. & Bird, C. E. Rethinking gender differences in health: why we need to integrate social and biological perspectives. J. Gerontol. Ser. B. 60, S40–S47. 10.1093/geronb/60.Special_Issue_2.S40 (2005). PubMed

Freedman, V. A., Wolf, D. A. & Spillman, B. C. Disability-Free life expectancy over 30 years: A growing female disadvantage in the US population. Am. J. Public. Health. 106, 1079–1085. 10.2105/AJPH.2016.303089 (2016). PubMed PMC